findmyKOL
Clinical trialNCT00714961CompletedPhase 3Interventional

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction

SponsorSanofiEnrollment3,491Acute Coronary Syndromes
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Sanofi-Aventis

    Buenos Aires, Argentina

Australia
  • Sanofi-Aventis

    Macquarie Park, Australia

Austria
  • Sanofi-Aventis Austria

    Vienna, Austria

Belgium
  • Sanofi-Aventis Belgium

    Diegem, Belgium

Brazil
  • Sanofi-Aventis Brazil

    São Paulo, Brazil

Canada
  • Sanofi-Aventis Canada

    Laval, Canada

France
  • Sanofi-Aventis France

    Paris, France

Germany
  • Sanofi-Aventis Germany

    Berlin, Germany

Hungary
  • Sanofi-Aventis Hungaria

    Budapest, Hungary

Ireland
  • Sanofi-Aventis

    Dublin, Ireland

Israel
  • Sanofi-Aventis

    Netanya, Israel

Italy
  • Sanofi-Aventis Italy

    Milan, Italy

Mexico
  • Sanofi-Aventis Mexico

    México, Mexico

Netherlands
  • Sanofi-Aventis Netherlands

    Gouda, Netherlands

Poland
  • Sanofi-Aventis Poland

    Warsaw, Poland

Portugal
  • Sanofi-Aventis

    Porto, Portugal

Puerto Rico
  • Sanofi-Aventis

    San Juan, Puerto Rico

Russia
  • Sanofi-Aventis

    Moscow, Russia

South Africa
  • Sanofi-Aventis South Africa

    Midrand, South Africa

Spain
  • Sanofi-Aventis Spain

    Barcelona, Spain

Sweden
  • Sanofi-Aventis Sweden

    Bromma, Sweden

Turkey (Türkiye)
  • Sanofi-Aventis

    Istanbul, Turkey (Türkiye)

United Kingdom
  • Sanofi-Aventis Uk

    Guildford, United Kingdom

United States
  • Sanofi-Aventis

    Bridgewater, New Jersey, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2003
Primary completion
31 Jan 2005
Completion
31 Jan 2005
Last update posted
25 Mar 2009
Registered enrollment
3,491
Registry id
NCT00714961

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.